| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
|
Bonnefoi, H.
|
|
|
27 |
5 |
p. 812-818
|
artikel
|
| 2 |
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma
|
Thomas, S.
|
|
|
27 |
5 |
p. 947-952
|
artikel
|
| 3 |
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)
|
Powles, T.
|
|
|
27 |
5 |
p. 880-886
|
artikel
|
| 4 |
Breakthrough therapies in B-cell non-Hodgkin lymphoma
|
Cheah, C.Y.
|
|
|
27 |
5 |
p. 778-787
|
artikel
|
| 5 |
Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975
|
Boniol, M.
|
|
|
27 |
5 |
p. 933-941
|
artikel
|
| 6 |
Dendritic cells stimulated by MUC1 antigen could induce lymphocytes' anergy through PD-L2 but not through PD-L1 patway
|
Wojas-Krawczyk, K.
|
|
|
27 |
5 |
p. 958-960
|
artikel
|
| 7 |
Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
|
Jamal-Hanjani, M.
|
|
|
27 |
5 |
p. 862-867
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
27 |
5 |
p. ii-iii
|
artikel
|
| 9 |
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer
|
Luchini, C.
|
|
|
27 |
5 |
p. 955-956
|
artikel
|
| 10 |
Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era
|
Cheah, C.Y.
|
|
|
27 |
5 |
p. 895-901
|
artikel
|
| 11 |
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
|
Cremolini, C.
|
|
|
27 |
5 |
p. 843-849
|
artikel
|
| 12 |
Identifying the potential long-term survivors among breast cancer patients with distant metastasis
|
Lee, E.S.
|
|
|
27 |
5 |
p. 828-833
|
artikel
|
| 13 |
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
|
Meric-Bernstam, F.
|
|
|
27 |
5 |
p. 795-800
|
artikel
|
| 14 |
Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
|
Bujko, K.
|
|
|
27 |
5 |
p. 834-842
|
artikel
|
| 15 |
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy
|
Servy, A.
|
|
|
27 |
5 |
p. 914-919
|
artikel
|
| 16 |
Molecular classification of gastric cancer
|
Chia, N.-Y.
|
|
|
27 |
5 |
p. 763-769
|
artikel
|
| 17 |
New drugs in acute myeloid leukemia
|
Kadia, T.M.
|
|
|
27 |
5 |
p. 770-778
|
artikel
|
| 18 |
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial †
|
Zdenkowski, N.
|
|
|
27 |
5 |
p. 806-812
|
artikel
|
| 19 |
Ovarian suppression during chemotherapy increases pregnancy rate in survivors
|
Blumenfeld, Z.
|
|
|
27 |
5 |
p. 953
|
artikel
|
| 20 |
PARP inhibitor receives FDA breakthrough therapy designation in castration resistant prostate cancer: beyond germline BRCA mutations
|
Helleday, T.
|
|
|
27 |
5 |
p. 755-757
|
artikel
|
| 21 |
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study
|
Nilsson, S.
|
|
|
27 |
5 |
p. 868-874
|
artikel
|
| 22 |
Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study
|
Michaud, D.S.
|
|
|
27 |
5 |
p. 941-947
|
artikel
|
| 23 |
Phosphoproteomics in translational research: a sarcoma perspective
|
Noujaim, J.
|
|
|
27 |
5 |
p. 787-794
|
artikel
|
| 24 |
Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014 †
|
Adra, N.
|
|
|
27 |
5 |
p. 875-879
|
artikel
|
| 25 |
Prognostic impact of extracapsular lymph node involvement in colorectal cancer
|
Huang, Q.
|
|
|
27 |
5 |
p. 955
|
artikel
|
| 26 |
Prognostic impact of extra-nodal extension on colon and rectal cancer should be investigated separately
|
Huang, Q.
|
|
|
27 |
5 |
p. 956-957
|
artikel
|
| 27 |
Reply to the letter to the editor ‘A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma’ by Rosati et al.
|
Hines, R.B.
|
|
|
27 |
5 |
p. 957-958
|
artikel
|
| 28 |
Reply to the letter to the editor ‘Number-Needed-To-Treat for pricing costly anti-cancer drugs. The example of Regorafenib in metastatic colorectal cancer’ by Graziano et al.
|
Pignatti, F.
|
|
|
27 |
5 |
p. 958
|
artikel
|
| 29 |
Reporting incidental germline variants in the context of day-to-day somatic genomic profiling
|
Mak, G.
|
|
|
27 |
5 |
p. 758-759
|
artikel
|
| 30 |
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer
|
Villaflor, V.M.
|
|
|
27 |
5 |
p. 908-913
|
artikel
|
| 31 |
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
|
Jones, M.R.
|
|
|
27 |
5 |
p. 801-806
|
artikel
|
| 32 |
Role of major resection in pulmonary metastasectomy for colorectal cancer in the Spanish prospective multicenter study (GECMP-CCR)
|
Hernández, J.
|
|
|
27 |
5 |
p. 850-855
|
artikel
|
| 33 |
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
|
Fouquet, G.
|
|
|
27 |
5 |
p. 902-907
|
artikel
|
| 34 |
Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29) †
|
Koeberle, D.
|
|
|
27 |
5 |
p. 856-861
|
artikel
|
| 35 |
Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan
|
Yoshimi, A.
|
|
|
27 |
5 |
p. 887-895
|
artikel
|
| 36 |
Statistical controversies in clinical research: statistical significance—too much of a good thing …
|
Buyse, M.
|
|
|
27 |
5 |
p. 760-762
|
artikel
|
| 37 |
Table of Contents
|
|
|
|
27 |
5 |
p. iv-vi
|
artikel
|
| 38 |
The global decrease in cancer mortality: trends and disparities
|
Hashim, D.
|
|
|
27 |
5 |
p. 926-933
|
artikel
|
| 39 |
The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis
|
Rusthoven, C.G.
|
|
|
27 |
5 |
p. 818-827
|
artikel
|
| 40 |
Transformation of ALK rearrangement-positive adenocarcinoma to small-cell lung cancer in association with acquired resistance to alectinib
|
Takegawa, N.
|
|
|
27 |
5 |
p. 953-955
|
artikel
|
| 41 |
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
|
Drilon, A.
|
|
|
27 |
5 |
p. 920-926
|
artikel
|
Tijdschrift beschrijving